As on July 14, 2021, Fulgent Genetics Inc. (NASDAQ: FLGT) started slowly as it slid -9.71% to $74.87. During the day, the stock rose to $83.59 and sunk to $74.77 before settling in for the price of $82.92 at the close. Taking a more long-term approach, FLGT posted a 52-week range of $18.80-$189.89.It was noted that the giant of the Healthcare sector posted annual sales growth of 113.20% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 88.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 38.10%. This publicly-traded company’s shares outstanding now amounts to $28.83 million, simultaneously with a float of $19.08 million. The organization now has a market capitalization sitting at $2.13 billion. At the time of writing, stock’s 50-day Moving Average stood at $77.81, while the 200-day Moving Average is $74.46.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 429 workers. It has generated 983,012 per worker during the last fiscal year. Meanwhile, its income per employee was 509,706. The stock had 3.99 Receivables turnover and 1.06 Total Asset turnover. For the Profitability, stocks gross margin was +78.70, operating margin was +68.80 and Pretax Margin of +69.17.
Fulgent Genetics Inc. (FLGT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Diagnostics & Research industry. Fulgent Genetics Inc.’s current insider ownership accounts for 4.50%, in contrast to 35.80% institutional ownership. According to the most recent insider trade that took place on Jun 04, this organization’s CFO and Treasurer sold 789 shares at the rate of 74.26, making the entire transaction reach 58,588 in total value, affecting insider ownership by 142,188. Preceding that transaction, on Jun 03, Company’s Director sold 125 for 74.17, making the whole transaction’s value amount to 9,271. This particular insider is now the holder of 2,000 in total.
Fulgent Genetics Inc. (FLGT) Earnings and Revenue Records
This company achieved a net margin of +51.85 while generating a return on equity of 67.06.
Fulgent Genetics Inc.’s EPS increase for this current 12-month fiscal period is 38.10% and is forecasted to reach 3.50 in the upcoming year.
Fulgent Genetics Inc. (NASDAQ: FLGT) Trading Performance Indicators
Let’s observe the current performance indicators for Fulgent Genetics Inc. (FLGT). It’s Quick Ratio in the last reported quarter now stands at 3.40. The Stock has managed to achieve an average true range (ATR) of 5.50. Alongside those numbers, its PE Ratio stands at $5.04, and its Beta score is 1.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.75. Similarly, its price to free cash flow for trailing twelve months is now 6.51.
In the same vein, FLGT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 14.85, a figure that is expected to reach 2.81 in the next quarter, and analysts are predicting that it will be 3.50 at the market close of one year from today.
Technical Analysis of Fulgent Genetics Inc. (FLGT)
Through scrutinizing the latest numbers posted by the [Fulgent Genetics Inc., FLGT], it can be observed that its last 5-days Average volume of 0.62 million was lower the volume of 1.47 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 14.77% While, its Average True Range was 5.69.
Raw Stochastic average of Fulgent Genetics Inc. (FLGT) in the period of the previous 100 days is set at 17.61%, which indicates a major rise in contrast to 0.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 79.06% that was lower than 80.71% volatility it exhibited in the past 100-days period.